More than six months after New York legalized adult-use cannabis through the Marijuana Regulation and Taxation Act (MRTA), the state’s Cannabis Control Board (CCB) held its first public meeting Oct. 5.
Inaction by former Gov. Andrew Cuomo in appointing a CCB chairperson as well as an executive director for the Office of Cannabis Management (OCM) held up the process. It took current Gov. Kathy Hochul nine days after assuming the governor’s office Aug. 24 to call an executive session to make those appointments.
So, what was the five-member board’s first order of business during its inaugural meeting this week? To expand New York’s medical cannabis program to include the use of whole flower.
New York OCM
CCB Chairwoman Tremaine Wright—Hochul’s appointee who was confirmed by the state Senate on Sept. 2—provided some detail about the “enhancements.”
“I am excited to announce that we are directing the OCM to work with the Department of Health (DOH) to execute the expansion of the medical cannabis program pursuant to the MRTA,” she said. “The Department of Health and our OCM team are actively working on several changes, which will take effect immediately.”
Wright said the changes